Clenoliximab (INN) is a monoclonal antibody against CD4. It acts as an immunomodulator and has been investigated for the treatment of rheumatoid arthritis...
2 KB (106 words) - 20:34, 1 December 2023
Cellular target CD3 Muromonab-CD3 Otelixizumab Teplizumab Visilizumab CD4 Clenoliximab Keliximab Zanolimumab CD11a Efalizumab CD18 Erlizumab CD20 Obinutuzumab...
7 KB (299 words) - 13:45, 27 April 2024
(CD221) solid tumors Clazakizumab mab humanized IL-6 rheumatoid arthritis Clenoliximab mab chimeric CD4 rheumatoid arthritis Clivatuzumab tetraxetan hPAM4-Cide...
136 KB (4,020 words) - 07:14, 15 August 2024
aritox Vepalimomab Zolimomab aritox Chimeric Andecaliximab† Basiliximab Clenoliximab Galiximab Gomiliximab Infliximab Keliximab Lumiliximab Priliximab Teneliximab...
38 KB (4,316 words) - 10:24, 26 August 2024
clemizole penicillin (INN) clemizole (INN) clenbuterol (INN) Clenia clenoliximab (INN) clenpirin (INN) clentiazem (INN) Cleocin cletoquine (INN) clevidipine...
12 KB (548 words) - 16:26, 16 May 2022
Cellular target CD3 Muromonab-CD3 Otelixizumab Teplizumab Visilizumab CD4 Clenoliximab Keliximab Zanolimumab CD11a Efalizumab CD18 Erlizumab CD20 Obinutuzumab...
38 KB (2,656 words) - 12:11, 30 October 2023
aritox Vepalimomab Zolimomab aritox Chimeric Andecaliximab† Basiliximab Clenoliximab Galiximab Gomiliximab Infliximab Keliximab Lumiliximab Priliximab Teneliximab...
2 KB (87 words) - 01:28, 30 May 2023